Digital Seminar

The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and other Mental Distress


Average Rating:
Not yet rated
Faculty:
Michael Mithoefer, MD |  Rick Doblin, Ph.D. |  Phil Wolfson, MD |  Sue Carter, PhD |  Robin Carhart-Harris, PhD |  Andrew Penn, RN, MS, NP, CNS, APRN-BC |  Richard C. Schwartz, Ph.D. |  Anne Wagner, PhD, C Psych |  James W. Hopper, Ph.D. |  Elizabeth Call, Psy.D. |  Susan Walker, MD |  Francis Guerriero, MA, LICSW |   2 more....
Duration:
3 Hours 59 Minutes
Copyright :
May 18, 2021
Product Code:
POS052719
Media Type:
Digital Seminar


Description

For the first time in over four decades, researchers are returning to examining the therapeutic benefits of mind-altering substances, including MDMA (ecstasy), psilocybin (mushrooms), marijuana and LSD.  In the 1970s the study of all psychedelics was criminalized in the US, despite emerging evidence of their medical value. Over the past decade, the Multidisciplinary Association for Psychedelic Research (MAPS) has helped to revive psychedelic research, sponsoring studies across the United States and around the world, including MDMA-assisted therapy for PTSD, and end-of-life anxiety. The results have been very positive, lasting over 72 months of follow-up, with few adverse effects. Psychedelics may promote a deepening and acceleration of the psychotherapeutic process. During therapy, people often are able to access and find peace with disavowed, “exiled” parts of themselves. In this workshop, the principal investigator of the Phase I and II level trials will discuss outcomes and processes. Two of the most prominent neurobiologists of psychedelics, Robin Carhart Harris and Sue Carter will present their findings about fundamental mechanisms, and the Boston MDMA study team will discuss clinical experiences and applications. In appropriate therapeutic contexts, psychedelics may prove to be more effective than most conventional treatments, as well as safer and more cost-effective.

Credits


**

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after completing and passing the on-line post-test evaluation). 

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact cepesi@pesi.com or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.


Addiction Counselors

This self-study activity consists of 3.0 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.


California Alcoholism & Drug Abuse Counselors (CADTP)

PESI, Inc. is an approved provider by the CADTP, Provider #: 201. This Category H activity meets the qualifications for 3.0 CEU's (continuing education hours).


Connecticut Addiction Counselors

Provider #120924. This course has been approved as a CCB approved training and has been awarded 3.25 hours by the Connecticut Certification Board.


Oklahoma Alcohol & Drug Counselors

PESI, Inc. is an Oklahoma Board of Licensed Alcohol and Drug Counselors approved provider #20220032. This self-study activity consists of 3.25 clock hours of continuing education instruction.


Counselors

This self-study activity consists of 3.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.


Florida Counselors

PESI, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number 50-399. This self-study course qualifies for 3.25 continuing education credits.


Kentucky Counselors

CE credit is available. This self-study course consists of 4.0 continuing education credit hours for Kentucky Counselors. The Continuing Education Requirements for the Kentucky Board of Licensed Professional Counselors (201 KAR 36:030 Section 2) state continuing education programs from providers sponsored or approved by a state counseling licensure board shall be approved without further review by the board. PESI, Inc. is approved by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540. PESI maintains responsibility for this program and its contents.


Montana Counselors

The Montana Board of Behavioral Health no longer pre-approves any courses or sponsors. Each licensee is responsible for taking courses which contribute to their competence and directly relate to their scope of practice as defined in board statute (MAR 24-219-32). Licensees must keep CE documentation for three years in case of an audit. This intermediate level self-study activity consists of 3.25 clock hours of instruction.


Nevada Counselors

PESI, Inc. is an approved CEU provider with the State of Nevada Board of Examiners for Marriage and Family Therapists and Clinical Professional Counselors. This self-study activity qualifies for 3.25 contact hours. Approved Provider # NVCEP2006.


South Carolina Counselors

This self-study program has been approved for 3.0 continuing education hours by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540.


Texas Counselors

This self-study activity consists of 3.0 clock hours of continuing education instruction. Texas State Board of Examiners of Professional Counselors no longer approves programs or providers. PESI activities meet the continuing education requirements as listed in Title 22 Texas Administrative Code, Chapter 681, Subchapter J, Section 681.142 Acceptable Continuing Education. Please retain the certificate of completion that you receive and use as proof of completion when required.


Marriage & Family Therapists

This self-study activity consists of 3.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save this course outline, the certificate of completion you receive from this self-study activity and contact your state board or organization to determine specific filing requirements. 


Florida Marriage & Family Therapists

PESI, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number 50-399. This self-study course qualifies for 3.25 continuing education credits.


Illinois Marriage & Family Therapists

PESI, Inc. has been approved as a provider of continuing education by the State of Illinois, Department of Professional Regulation. Provider #:168-000156. Full attendance at this self-study activity qualifies for 3.0 credits.


Montana Marriage & Family Therapists

The Montana Board of Behavioral Health no longer pre-approves any courses or sponsors. Each licensee is responsible for taking courses which contribute to their competence and directly relate to their scope of practice as defined in board statute (MAR 24-219-32). Licensees must keep CE documentation for three years in case of an audit. This intermediate level self-study activity consists of 3.25 clock hours of instruction.


Nevada Marriage & Family Therapists

PESI, Inc. is an approved CEU provider with the State of Nevada Board of Examiners for Marriage and Family Therapists and Clinical Professional Counselors. This self-study activity qualifies for 3.25 contact hours. Approved Provider # NVCEP2006.


South Carolina Marriage & Family Therapists

This self-study program has been approved for 3.0 continuing education hours by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540.


Texas Marriage & Family Therapists

This self-study activity consists of 3.0 clock hours of continuing education instruction. Texas State Board of Examiners of Marriage and Family Therapists no longer approves programs or providers. PESI activities meet the continuing education requirements as listed in Title 22 of the Texas Administrative Code, Chapter 801, Subchapter K, Section 801.264 Types of Acceptable Continuing Education. Please retain the certificate of completion that you receive and use as proof of completion when required.


Nurses, Nurse Practitioners, and Clinical Nurse Specialists

This self-study activity consists of 3.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from this self-study activity and contact your state board or organization to determine specific filing requirements.


California Nurses

PESI, Inc. is a provider approved by the California Board of  Registered Nursing, Provider #: 17118 for 3.0 self-study contact hours. 

** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.


Florida Nurses

PESI, Inc. is an approved provider by the Florida Board of  Nursing. Provider #: FBN2858. These materials qualify for 3.0 self-study contact hours.

CE Broker


Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 3.3 self-study contact hours. Please email cepesi@pesi.com with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.


California Psychologists

CE credit is available. This self-study course consists of 3.0 continuing education credit hours for California Psychologists. The California Department of Consumer Affairs Board of Psychology recognizes and accepts for continuing education credit courses that are specifically applicable and pertinent to the practice of psychology and by entities approved by the ACCME (Accreditation Council for Continuing Medical Education). This enduring material is certified for a maximum of 3.0 AMA PRA Category 1 Credits™ by PESI as an accredited ACCME provider authorized to award credit by the AMA. PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Florida Psychologists

PESI, Inc., is an approved provider with the Florida Board of Psychology.Provider Number #50-399.This product qualifies for 3.3 self-study continuing education credits.


Illinois Psychologists

 

PESI, Inc is an approved provider with the State of Illinois, Department of Professional Regulation. License #: 268.000102. Full attendance at this self-study course qualifies for 3.0 contact hours.


Kentucky Psychologists

PESI, Inc. is approved by the Kentucky Psychological Association and/or Kentucky Board of Examiners of Psychology to offer continuing education for psychologists. PESI maintains responsibility for this program and its content. This self-study activity will qualify for 3.25 contact hours.


Ohio Psychologists

PESI, Inc. is approved by the Ohio Psychological Association, Provider #263896894, to sponsor continuing education for psychologists. PESI, Inc. maintains responsibility for this program and its content. PESI is offering this self-study activity for 3.25 Standard hours of continuing education credit.


Pennsylvania Psychologists

PESI, Inc. is approved by the Pennsylvania State Board of Psychology to offer continuing education for psychologists. Provider #PSY000211. PESI maintains responsibility for the program(s). This self-study program qualifies for 3.25 continuing education hours.


Psychologists & Physicians

Physicians: PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. This activity was originally recorded on 05/18/2021. It was last reviewed on 05/03/2021 and is valid until 05/03/2024.  Physicians should only claim credit commensurate with the extent of their participation in the activity. You are required to successfully complete and submit a post-test prior to receiving a certificate of completion.


Psychologists: The following state psychologist boards recognize activities sponsored by PESI, Inc. as an approved ACCME provider: Alaska, Arkansas, California, Colorado, Georgia, Illinois, Indiana, Kentucky, Maine, Maryland, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, Oklahoma, Pennsylvania, South Carolina and Wisconsin. This activity consists of 3.0 clock hours of continuing education instruction. You are required to successfully complete and submit a post-test prior to receiving a certificate of completion.


Social Workers

This intermediate self-study activity consists of 3.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.


Colorado Social Workers

PESI, Inc. is an approved provider with the Colorado Chapter of the National Association of Social Workers. Provider #1413. This self-study course has been approved for 3.3 continuing education hours. 

 

COLORADO PARTICIPANTS ONLY: If you did not answer YES to be reported to the Colorado Chapter of the NASW on the evaluation, please contact cepesi@pesi.com and provide the full title of the webcast, speaker name, date of live broadcast, your name and your license number in the email.


Florida Social Workers

PESI, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number 50-399. This self-study course qualifies for 3.25 continuing education credits. 


Illinois Social Workers

PESI, Inc. is an approved provider with the State of Illinois, Department of Financial and Professional Regulation, Division of Professional Regulation. License #: 159-000154. Successful completion of this self-study activity qualifies for 3.0 contact hours.


Minnesota Social Workers

PESI, Inc. is an approved provider with the State of Minnesota, Board of Social Work. Provider #: CEP-140. This self-study package has been approved for 3.0 continuing education hours. This certificate has been issued upon successful completion of a post-test.


Montana Social Workers

The Montana Board of Behavioral Health no longer pre-approves any courses or sponsors. Each licensee is responsible for taking courses which contribute to their competence and directly relate to their scope of practice as defined in board statute (MAR 24-219-32). Licensees must keep CE documentation for three years in case of an audit. This intermediate level self-study activity consists of 3.25 clock hours of instruction.


Other Professions

This self-study activity qualifies for 3.25 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.



Handouts

Faculty

Michael Mithoefer, MD's Profile

Michael Mithoefer, MD Related seminars and products


Michael Mithoefer, MD, clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.

 

Speaker Disclosures:

Financial: Michael Mithoefer receives a salary and grants from MAPS Public Benefit Corp and is a clinical assistant professor at the Medical University of South Carolina.

Non-financial: Michael Mithoefer is a member of the non-profit MAPS.

 


Rick Doblin, Ph.D.'s Profile

Rick Doblin, Ph.D. Related seminars and products


Rick Doblin, Ph.D., Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS); chair of the board of directors MAPS Public Benefit Corporation.

 

Speaker Disclosures:

Financial: Richard Doblin is the founder and executive director for the Multidisciplinary Association for Psychedelic Studies, Inc.
Non-financial: Richard Doblin has no relevant non-financial relationship to disclose.

 


Phil Wolfson, MD's Profile

Phil Wolfson, MD Related seminars and products


Phil Wolfson, MD, is Principal Investigator for a Phase 2, FDA approved 18-person study of MDMA Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine Assisted Psychotherapy. Phil’s book The Ketamine Papers has been published by MAPS and is the seminal work in the burgeoning ketamine arena. Phil is a sixties activist, psychiatrist/psychotherapist, writer, practicing Buddhist and psychonaut who has lived in the Bay Area for 38 years. He is the author of Noe – A Father/Son Song of Love, Life, Illness and Death (2011, North Atlantic Books). In the 1980s, he participated in clinical research with MDMA (Ecstasy). He has been awarded five patents for unique herbal medicines. He is a journalist and author of numerous articles on politics, transformation, psychedelics, consciousness and spirit, and was a founding member of the Heffter Research Institute. Phil has taught in the graduate psychology programs at JFK University, CIIS and the UCSF School of Medicine Department of Psychiatry.

 

Speaker Disclosures:
Financial: Philip Wolfson is the founder and CEO of The Ketamine Research Foundation. He has an ownership interest in Progressive Therapeutics, Inc. Dr. Wolfson will address off-label uses.
Non-financial: Philip Wolfson has no relevant non-financial relationship to disclose.

 


Sue Carter, PhD's Profile

Sue Carter, PhD Related seminars and products


C. Sue Carter, PhD, is Distinguished University Scientist, Rudy Professor Emerita of Biology at Indiana University Bloomington and from 2014-2019 was Director of the Kinsey Institute. She is Professor Emerita at the University of Illinois at Chicago and formerly held the position of Distinguished University Professor of Biology at the University of Maryland and prior to that was Professor in the Departments of Psychology and Ecology, Ethology and Evolution at the University of Illinois, Urbana-Champaign. Dr. Carter is a past president of the International Behavioral Neuroscience Society and holds fellow status in that Society and in the American Association for the Advancement of Science. She has a career long history of federal research funding include an NIMH Research Scientist Award. Dr. Carter is the scientist who discovered the relationship between social behavior and oxytocin. Her current work examines the developmental consequences of oxytocin and the role of oxytocin pathways in human sociality.

 

Speaker Disclosures:
Financial: C. Sue Carter is the Distinguished University Research Scientist and Rudy Professor Emerita of Biology at Indiana University.
Non-financial: C. Sue Carter has no relevant non-financial relationship to disclose.

 


Robin Carhart-Harris, PhD's Profile

Robin Carhart-Harris, PhD Related seminars and products


Robin Carhart-Harris, PhD, is a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London. He coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years.

After being awarded an MA in Psychoanalysis at Brunel University, London, Carhart-Harris completed his PhD in psychopharmacology at the University of Bristol. In 2009, under the mentorship of Professor David Nutt, he relocated to Imperial College, London to continue his fMRI research with the classic psychedelic psilocybin. In conjunction with David Nutt, he built up a program of psychedelic research that includes fMR and MEG imaging with psilocybin, fMR imaging with MDMA, and plans for an MRC-sponsored clinical trial to assess the efficacy of psilocybin as a treatment for major depression.

Speaker Disclosures:
Financial: Robin Carhart-Harris is the Head of Centre for Psychedelic Research at Imperial College London.
Non-financial: Robin Carhart-Harris is a member of the Association for Psychological Services; Neuropsychoanalysis Association; International Society for Research on Psychedelics; and the British Association for Psychopharmacology. He is an advisory council member for the Massachusetts General Hospital, Psychedelic Research Centre.


Andrew Penn, RN, MS, NP, CNS, APRN-BC's Profile

Andrew Penn, RN, MS, NP, CNS, APRN-BC Related seminars and products


Andrew Penn MS, PMHNP, UC San Francisco trained psychiatric nurse practitioner. Associate clinical professor in the UCSF School of Nursing, practicing at the San Francisco VA. He has worked as study therapist on a MDMA-assisted therapy protocol for PTSD.

 

Speaker Disclosures:
Financial: Andrew Penn is an associate clinical professor at UCSF School of Nursing. He has an employment relationship with the San Francisco Veterans Administration Hospital. He is a steering committee member and nurse planner for North American Center for Continuing Medical Education (NACCME). Mr. Penn is a study therapist for Multidisciplinary Association for Psychedelics Studies, UCSF Langley Porter Institute, BAND Lab. He will address off-label uses.
Non-financial: Andrew Penn is the co-founder of the Organization of Psychedelic and Entheogenic Nurses. He is the founder of UCSF School of Nursing Psychedelic Therapy Journal Club. Mr. Penn is a member of the American Psychiatric Nurses Association.

 


Richard C. Schwartz, Ph.D.'s Profile

Richard C. Schwartz, Ph.D. Related seminars and products

Owner

The Center for Self Leadership


Richard Schwartz began his career as a family therapist and an academic at the University of Illinois at Chicago. There he discovered that family therapy alone did not achieve full symptom relief and in asking patients why, he learned that they were plagued by what they called "parts." These patients became his teachers as they described how their parts formed networks of inner relationship that resembled the families he had been working with. He also found that as they focused on and, thereby, separated from their parts, they would shift into a state characterized by qualities like curiosity, calm, confidence and compassion. He called that inner essence the Self and was amazed to find it even in severely diagnosed and traumatized patients. From these explorations, the Internal Family Systems (IFS) model was born in the early 1980s.

IFS is now evidence-based and has become a widely-used form of psychotherapy, particularly with trauma. It provides a non-pathologizing, optimistic, and empowering perspective and a practical and effective set of techniques for working with individuals, couples, families, and more recently, corporations and classrooms.

In 2013, Schwartz left the Chicago area and now lives in Brookline, MA where he is on the faculty of the Department of Psychiatry at Harvard Medical School.

 

Speaker Disclosures:

Financial: Richard Schwartz is the Founder of The Center for Self Leadership. He receives a speaking honorarium from PESI, Inc.

Non-financial: Richard Schwartz is a Fellow and member of the American Association for Marital and Family Therapy.


Anne Wagner, PhD, C Psych's Profile

Anne Wagner, PhD, C Psych Related seminars and products


Anne Wagner, PhD, Adjunct Professor, Department of Psychology & Associate Member, Yeates School of Graduate Studies at Ryerson University, Toronto. Trainer in CBCT and CPT. Team member, MDMA trial for Cognitive Behavioral Conjoint Therapy (CBCT) for PTSD. Founder of Remedy (www.remedycentre.ca), a centre for mental health innovation.

 

Speaker Disclosures:
Financial: Anne Wagner is the founder of Remedy. She is an adjunct professor, department of Psychology at Ryerson University. Dr. Wagner is an associate member, Yeates School of Graduate Studies at Ryerson University.
Non-financial: Anne Wagner serves on the board of directors for Casey House. She is a member of the Canadian Psychological Association – Traumatic Stress Section; International Society of Traumatic Stress Studies; the Ontario Psychological Association; International Society for Psychedelic Research; and the Association for Behavioral and Cognitive Therapies – Trauma and PTSD Special Interest Group.

 


James W. Hopper, Ph.D.'s Profile

James W. Hopper, Ph.D. Related seminars and products


James W. Hopper, Ph.D., Independent consultant and instructor in psychology, Cambridge Health Alliance & Harvard Medical School. Co-editor, Mindfulness-oriented interventions for trauma: Integrating contemplative practices. The MDMA Team, Trauma Research Foundation.


Speaker Disclosures:
Financial: James Hopper is a teaching associate at Harvard Medical School; and at Cambridge Health Alliance. He is a sub-investigator and therapist at The Trauma Research Corporation. Dr. Hopper will address off-label uses.
Non-financial: James Hopper is a member of the International Society for Traumatic Stress Studies. He is on the advisory board for Callisto.

 


Elizabeth Call, Psy.D.'s Profile

Elizabeth Call, Psy.D. Related seminars and products


Elizabeth Call, Psy.D., Psychologist in private practice. Therapy team member, MDMA study, the Trauma Research Foundation.


Speaker Disclosures:

Financial: Elizabeth Call maintains a private practice. She receives a consulting fee from the Multidisciplinary Association for Psychedelic Studies (MAPS). Dr. Call receives a speaking honorarium from PESI, Inc.
Non-financial: Elizabeth Call has no relevant non-financial relationship to disclose.


Susan Walker, MD's Profile

Susan Walker, MD Related seminars and products


Susan Walker, MD, Instructor in psychiatry, Harvard Medical School.  Child and Adolescent Psychiatrist, Cambridge Health Alliance. MDMA Therapy Team Member, the Trauma Research Foundation.

 

Speaker Disclosures:
Financial: Susan Walker is a clinical sub-investigator at the Trauma Research Foundation. She will address off-label uses.
Non-financial: Susan Walker is a member of the American Psychiatric Association; the Massachusetts Psychiatric Association; the New England Council of Child and Adolescent Psychiatry; and the American Academy of Child and Adolescent Psychiatry.

 


Francis Guerriero, MA, LICSW's Profile

Francis Guerriero, MA, LICSW Related seminars and products


Francis Guerriero, MA, LICSW, Private practice, Cambridge, MA; MDMA Therapy team member, The Trauma Research Foundation.


Speaker Disclosures:
Financial: Francis Guerriero maintains a private practice. He will address off-label uses.
Non-financial: Francis Guerriero has no relevant non-financial relationship to disclose.

 


Michael Alpert, MD's Profile

Michael Alpert, MD Related seminars and products


Michael D. Alpert, MD, Psychiatrist, South Cove Community Health Center, Boston Harvard Medical School; MDMA Therapy team member, the Trauma Research Foundation.



Speaker Disclosures:
Financial: Michael Alpert is a clinical faculty member of the Beth Israel Deaconess Medical Center-Harvard Medical School. He is an attending psychiatrist at South Cove Community Health Center. Dr. Alpert is a therapist with the Multidisciplinary Association of Psychedelic Studies. He is a mental health consultant for Skadden, Arps, Slate, Meagher, & Flom, LLP. He will address off-label uses.
Non-financial: Michael Alpert has no relevant non-financial relationship to disclose.


Bessel van der Kolk, M.D.'s Profile

Bessel van der Kolk, M.D. Related seminars and products


Bessel A. van der Kolk, M.D., is a clinician, researcher and teacher in the area of post-traumatic stress.  His work integrates developmental, neurobiological, psychodynamic and interpersonal aspects of the impact of trauma and its treatment.

Dr. van der Kolk and his various collaborators have published extensively on the impact of trauma on development, such as dissociative problems, borderline personality and self-mutilation, cognitive development, memory, and the psychobiology of trauma.  He has published over 150 peer reviewed scientific articles on such diverse topics as neuroimaging, self-injury, memory, neurofeedback, Developmental Trauma, yoga, theater, and EMDR. 

He is founder of the Trauma Center in Brookline, Massachusetts, and President of the Trauma Research Foundation, which promotes clinical, scientific, and educational projects. 

His 2014 #1 New York Times best seller, The Body Keeps the Score: Brain, Mind, and Body in the Treatment of Trauma, transforms our understanding of traumatic stress, revealing how it literally rearranges the brain’s wiring – specifically areas dedicated to pleasure, engagement, control, and trust.  He shows how these areas can be reactivated through innovative treatments including neurofeedback, somatically based therapies, EMDR, psychodrama, play, yoga, and other therapies.

Dr. van der Kolk is the past president of the International Society for Traumatic Stress Studies, and professor of psychiatry at Boston University Medical School.  He regularly teaches at conferences, universities, and hospitals around the world.

Speaker Disclosures:

Financial: Bessel van der Kolk is a professor of psychiatry at the Boston University School of Medicine.  He receives a speaking honorarium from PESI, Inc.

Non-financial:  Bessel van der Kolk has no relevant non-financial relationship to disclose.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Objectives

  1. Debate the emerging research of MDMA-Assisted Psychotherapy (MDMA-AP) and describe effective ways of integrating it into ongoing psychotherapy to improve clinical outcomes for clients with PTSD. 
  2. Investigate the history and contemporary research of Psilocybin and evaluate the effectiveness of Psilocybin-Assisted Psychotherapy (PAP) in facilitating psychotherapy. 
  3. Synthesize methods of integration of psychedelic-assisted therapy in contemporary treatment for mental illness. 
  4. Differentiate key areas of investigation regarding therapeutic potentials of classic 5-HT2A agonist psychedelics for mental healthcare. 

Outline

  • The emerging research on MDMA and MDMA-Assisted Psychotherapy 
  • The history and contemporary research on Psilocybin and Psilocybin-Assisted Psychotherapy 
  • Integration of psychedelics in contemporary treatments for mental illness 
  • Investigations regarding neurotransmitters and psychedelics 

Target Audience

  • Counselors
  • Social Workers
  • Psychologists
  • Psychotherapists
  • Therapists
  • Marriage & Family Therapists
  • Addiction Counselors
  • Case Managers
  • Physicians
  • Nurses
  • Other Mental Health Professionals

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

Please wait ...

Back to Top